Cellular immune function in mice tolerant to or abstinent from /-trans-Δ9-tetrahydrocannabinol

Pharmacology

Volumn 52, Issue 5, 1996, Pages 271-282

  Bhargava, Hemendra N ^a   House, Robert V ^b   Thorat, Sanjay N ^a   Thomas, Peter T ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b IIT RESEARCH INSTITUTE   (United States)

Author keywords

Cannabinoids; Cytokines; Drug abuse; Immune system; Natural killer cells; Tetrahydrocannabinol, tolerance abstinence

Indexed keywords

DRONABINOL; INTERLEUKIN 2; INTERLEUKIN 4;

ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELLULAR IMMUNITY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DRUG TOLERANCE; FEMALE; HELPER CELL; HYPOTHERMIA; IMMUNOLOGICAL TOLERANCE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN WEIGHT; SUBCUTANEOUS DRUG ADMINISTRATION; TAIL FLICK TEST; THYMUS;

ANALGESICS; ANIMALS; B-LYMPHOCYTES; BODY WEIGHT; CELL DIVISION; CYTOKINES; DRUG TOLERANCE; FEMALE; IMMUNITY, CELLULAR; KILLER CELLS, NATURAL; MALE; MICE; MICE, INBRED STRAINS; ORGAN SIZE; PSYCHOTROPIC DRUGS; SPLEEN; SUBSTANCE WITHDRAWAL SYNDROME; T-LYMPHOCYTES, CYTOTOXIC; TETRAHYDROCANNABINOL;

EID: 0029931578     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000139392     Document Type: Article

References (49)

1. Chiang W, Goldfrank L: The medical complications of drug abuse, McdJAust 1990;152:83-88.
2. Pillai RM, Watson RR: In vitro im-munotoxicology and immunophar-macology: Studies on drugs of abuse, Toxicol Lett 1990;53:269-283.
3. Schulz JE: Illicit drugs of abuse, Prim Care 1993;20:221-229.
4. Levy M, Hcppner JH: Immunosuppression by marihuana and its can-nabinoid constituents, J Immuno-pharmacol 1980;2:159-177.
5. Klein TW, Friedman H: Modulation of murine immune cell function by marijuana components; in Watson RR (cd): Drugs of Abuse and Immune Function, Boca Raton, CRC Press, 1990, pp 88-111.
6. Specter S, Lancz G, Goodfcllow D: Suppression of human macrophage function in vitro by tetrahydrocannabinol, J Leukoc Biol 1991;50: 423-426.
7. Hollister I.E: Marijuana and immunity, J Psvchoactivc Drugs 1988;20: 3-8.
8. 9-telrahydrocannabinol in mice, Eur J Pharmacol 1994;260:5-13.
9. Bhargava HN, Thomas PT, Thorat SN, House RV: Effects of morphine tolerance and abstinence on cellular immune function, Brain Res 1994; 642:1-10.
10. House RV, Thomas PT, Bhargava HN: Comparison of immune functional parameters following in vitro exposure to natural and synthetic amphetamines, Immunopharmacol Immunotoxicol 1994:16:1-21.
11. Gillis S, Form MM, Ou W, Smith KA: T cell growth factor: Parameters of production and a quantitative microassay for activity, J Immunol 1978:120:2027-2032.
12. Hu-Li J, Ohara J, Watson CJ, Tsang W, Paul WE: Derivation of a T cell line that is highly responsive to 1L-4 and 1L-2 (CT.4R) and an 1L-2 hy-poresponsive mutant of that line (CT.4S), J Immunol 1989:142:800-807.
13. Reynolds CW, Herberman RB: In vitro augmentation of rat natural killer (NK) cell activity, J Immunol 1981;126:1581-1585.
14. Bhargava HN, House RV, Thorat SN, Thomas PT: Effects of naltrexone on morphine-induced tolerance and physical dependence and changes in cellular immune function in mice, Brain Res 1995:690:121-126.
15. 9-Tetrahydrocannabinol selectively inhibits T-cell dependent humoral immune responses through direct inhibition of accessory T-cell function, Immunopharmacology 1993: 26:129-137.
16. Mosmann TR, Schumacher JH, Street NF, Budd R, O’Garra A, Fong TAT, Bond MW, Moore KWM, Slier A, Fiorentino DF: Diversity of cytokine synthesis and function of mouse CD4+ T cell, Immunol Rev 1991; 123:209-229.
17. Blanchard DK, Newton C, Klein TW, Stewart WE, Friedman H: In vitro and in vivo suppressive effects of dclta-9-tctrahydrocannabinol on interferon production by murine spleen cells, Int J Immunopharmacol 1986:8:819-824.
18. Watzl B, Schudcri P, Watson RR: Marijuana components stimulate human peripheral blood mononuclear cell secretion of interferon-gamma and suppress interleukin-1 alpha in vitro, Int J Immunopharmacol 1991:13:1091-1097.
19. 9-tct rahy-drocannabinol (THC), on the synthesis of tumor necrosis factor by human large granular lymphocytes, Cell Immunol 1994:154:99-108.
20. Newton CA, Klein TW, Friedman H: Secondary immunity to Legionella pneumophila and Th 1 activity are suppressed by delta-9-tetrahy-drocannabinol injection, Infect Immun 1994;62:4015-4020.
21. Zhu W, Igarashi T, Qi ZT, Newton C, et al: Dclta-9-tetrahydrocannabi-nol (THC) decreases the number of high and intermediate affinity 1L-2 receptors of the IL-2 dependent cell line NKB61A2, Int J Immunopharmacol 1993;15:401-408.
22. Zhu W, Newton C, Daaka Y, Friedman H, Klein TW: Delta-9-tetrahy-drocannabinol enhances the secretion of interleukin 1 from endotoxin-stimulated macrophages, J Pharmacol Exp Ther 1994:270:1334-1339.
23. Berkc G: The binding and lysis of target cells by cytotoxic lymphocytes, Molecular and cellular aspects, Annu Rev Immunol 1994:12: 735-773.
24. Klein TW, Kawakami Y, Newton C, Friedman H: Marijuana components suppress induction and cytolytic function of murine cyotoxic T cells in vitro and in vivo, J Toxicol Environ Health 1991;32:465-477.
25. House RV, Pallardy MJ, Cornacolt JB, Thurmond LM, Dean JH: Suppression of cytolytic function in murine lymphocytes exposed to 1.4-bis[(2-aminoethyl)amino]-5.8-dihydroxy-9, 10-anthracencdione dihydrochloride (AEAD): Inhibition of proliferation by cytotoxic T-lym-phocyte precursors, Int J Immunopharmacol 1989;11:301-308.
26. Lotzovà E: Definition and functions of natural killer cells, Nat Immun 1993:12:169-176.
27. Talmadgc JE: Immunoregulation and immunostimulation of murine lymphocytes by recombinant human interleukin-2, J Biol Response Modif 1985;4:18-34.
28. Johnson AG: Regulation of the immune system by nucleic acids and polynucleotides; in Torrence PR (ed), Biological Response Modifiers: New Approaches to Disease Intervention, New York, Academic Press, 1985, pp 107-119.
29. 9-tctrahydrocanna-binol administration on the plasma catecholamine, β-endorphin, and corticosterone levels and splenic natural killer cell activity in rats, Proc Soc Exp Biol Med 1985:180: 400-404.
30. Specter SC, Klein TW, Newton C, Mondragon M, Widen R, Friedman H: Marijuana effects on immunity: Suppression of human natural killer cell activity by delta-9-tetrahydro-cannabinol, Int J Immunopharmacol 1986;7:741-745.
31. Specter S, Rivenbark M, Newton C, Kawakami Y, Lancz G: Prevention and reversal of delta-9-tetrahydro-cannabinol induced depression of natural killer cell activity by inter-lcukin-2, Int J Immunopharmacol 1989;11:63-69.
32. Klein TW, Newton C, Friedman H: Inhibition of natural killer cell function by marijuana components, J Toxicol Environ Health 1987;20: 321-332.
33. Kawakami Y, Klein TW, Newton C, Djeu JY, Specter S, Friedman H: Suppression by delta-9-tetrahydro-cannabinol of interleukin-2-induccd lymphocyte proliferation and lym-phokine-activated killer cell activity, Int J lmmmunopharmacol 1988; 10:485-488.
34. Wang M, Richards AL, Friedman H, Djeu JY: Selective inhibition of natural killer but not natural cytotoxic activity in a cloned cell line by delta-9-tetrahydrocannabinol, J Lcukoc Biol 1991;50:192-197.
35. Kusnecov AW, Rabin BS: Stressor-induced alterations ofimmunc function: Mechanisms and issues, Int Arch Allergy Immunol 1994; 105: 107-121.
36. Morahan PS, Klykkcn PC, Smith SH, Harris LS, Munson AE: Effects of cannabinoids on host resistance to Listeria monocytogenes and herpes simplex virus, Infect Immun 1979;22:670-674.
37. Cabral GA, Lockmuller JC, Mishkin EM: A’-Tetrahydrocannabinol decreases alpha/beta interferon response to herpes simplex virus type 2 in the B6C3FI mouse, Proc Soc Exp Biol Med 1986; 181:305-311.
38. Cabral GA, McNerney PJ, Mishkin EM: Delta-9-tetrahydrocannabino! inhibits the splénocyte proliferative response to herpes simplex virus type 2, Immunopharmacol Immu-notoxicol 1987;9:361-370.
39. Specter S, Lancz G, Westrich G, Friedman H: Delta-9-tetrahydro-cannabinol augments murine retroviral induced immunosuppression and infection, Int J Immunopharmacol 1991;13:411-417.
40. Arata S, Klein TW, Newton C, Friedman H: Tetrahydrocannabinol treatment suppresses growth restriction of Legionella pneumophila in murine macrophage cultures, Life Sei 1991:49:473-479.
41. Bradley SG: Drugs of abuse and infections: in Friedman H (ed): Drugs of Abuse, Immunity, and Immunodeficiency, New York, Plenum Press, 1991, pp 119-125.
42. Mcchoulam R, Shani A, Edery H, Grunfcld Y: Chemical basis of hashish activity, Science 1970:169: 611-612.
43. Dcvanc WA, Dysarz FAI, Johnson MR, Melvin LS, Howlett AC: Determination and characterization of a cannabinoid receptor in rat brain, Mol Pharmacol 1988;34:605-613.
44. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice KC: Cannabinoid receptor localization in brain, Proc Natl Acad Sci USA 1990:87:1932-1936.
45. Oviedo A, Glowa J, Herkenham M: Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: A quantitative autoradiographic study, Brain Res 1993;616:293-302.
46. Rodriguez de Fonseca F, Gorriti MA, Fcmandez-Ruiz JJ, Palomo T, Ramos JA: Down-regulation of rat brain cannabinoid binding sites after chronic A'Metrahydrocannabinol treatment, Pharmacol Biochem Be-hav 1994:47:33-40.
47. Munro S, Thomas KL, Abu-Shaar M: Molecular characterization of a peripheral receptor for cannabinoids, Nature 1993:365:61-65.
48. Kaminski NE, Abood ME, Kessler FK, Martin BR, Schatz AR: Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabi-noid-mediated immune modulation, Mol Pharmacol 1992:42:736-742.
49. Lynn AB, Herkenham M: Localization of cannabinoid receptors and nonsaturable high density cannabinoid binding sites in peripheral tissues of the rat: Implications for receptor-mediated immune modulation by cannabinoids, J Pharmacol ExpTher 1994:268:1612-1623.